PubMed

Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Rosenfeld PJ.

Br J Ophthalmol. 2007 Feb;91(2):128-30. No abstract available. PMID: 17244654 [PubMed - indexed for MEDLINE]Related articles

Avastin in myopic choroidal neovascularisation: is age the limit?

Wong D, Li KK.

Br J Ophthalmol. 2008 Aug;92(8):1011-2. No abstract available. PMID: 18653589 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.

Tewari A, Dhalla MS, Apte RS.

Retina. 2006 Nov-Dec;26(9):1093-4. No abstract available. PMID: 17151505 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.

Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.

Br J Ophthalmol. 2007 Feb;91(2):157-60. Epub 2006 Jul 26.PMID: 16870653 [PubMed - indexed for MEDLINE]Related articles

Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.

Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y.

Br J Ophthalmol. 2007 Feb;91(2):161-5. Epub 2006 Aug 16.PMID: 16914470 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.

Laud K, Spaide RF, Freund KB, Slakter J, Klancnik JM Jr.

Retina. 2006 Oct;26(8):960-3. No abstract available. PMID: 17031300 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O, Roca G.

Br J Ophthalmol. 2008 Aug;92(8):1035-9. Review.PMID: 18653595 [PubMed - indexed for MEDLINE]Related articles

Papulopustular eruption after intravitreal bevacizumab (Avastin).

Amselem L, Diaz-Llopis M, Garcia-Delpech S, Montero J, Palomares P, Cervera E.

Acta Ophthalmol. 2009 Feb;87(1):110-1. Epub 2008 Jun 18. No abstract available. PMID: 18577190 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia.

Rhéaume MA, Sebag M.

Can J Ophthalmol. 2008 Oct;43(5):576-80.PMID: 18982035 [PubMed - indexed for MEDLINE]Related articlesFree article

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

Nguyen QD, Shah S, Tatlipinar S, Do DV, Anden EV, Campochiaro PA.

Br J Ophthalmol. 2005 Oct;89(10):1368-70. No abstract available. Erratum in: Br J Ophthalmol. 2006 Jan;90(1):125. PMID: 16170134 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitritis in the contralateral uninjected eye following intravitreal bevacizumab (Avastin).

Neri P, Mariotti C, Mercanti L, Salvolini S, Giovannini A.

Int Ophthalmol. 2008 Dec;28(6):425-7. Epub 2007 Oct 13.PMID: 17934693 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y.

Am J Ophthalmol. 2009 Jan;147(1):94-100.e1. Epub 2008 Sep 6.PMID: 18774550 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS.

Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization.

Mandal S, Venkatesh P, Sampangi R, Garg S.

Eur J Ophthalmol. 2007 Jul-Aug;17(4):620-6.PMID: 17671940 [PubMed - indexed for MEDLINE]Related articles

Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.

Teixeira A, Moraes N, Farah ME, Bonomo PP.

Acta Ophthalmol Scand. 2006 Dec;84(6):835-6. No abstract available. PMID: 17083556 [PubMed - indexed for MEDLINE]Related articles

Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.

Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, Fromow-Guerra J, Amaya-Espinosa A, Solís-Vivanco A, Reyna-Castelán E, Abraham-Marín M, Martínez-Castellanos MA, Aiello LP.

Retina. 2007 Jul-Aug;27(6):707-12.PMID: 17621179 [PubMed - indexed for MEDLINE]Related articles

Intravitreal avastin: the low cost alternative to lucentis?

Rosenfeld PJ.

Am J Ophthalmol. 2006 Jul;142(1):141-3. No abstract available. PMID: 16815262 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.

Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.

Am J Ophthalmol. 2009 Jan;147(1):84-93.e1. Epub 2008 Sep 6.PMID: 18774547 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS.

Br J Ophthalmol. 2009 Feb;93(2):150-4. Epub 2008 Sep 18.PMID: 18801766 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy.

Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Hara W, Yoshida T, Tokoro T, Mochizuki M.

Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):609-18. Epub 2009 Jan 16.PMID: 19148667 [PubMed - indexed for MEDLINE]Related articles